首页> 外文会议>Conference on single-use technologies III >USE OF THE AMBR 250 TO ENABLE RAPID CLONE SELECTION AND PROCESS DEVELOPMENT FOR LARGE SCALE MANUFACTURING PROCESSES
【24h】

USE OF THE AMBR 250 TO ENABLE RAPID CLONE SELECTION AND PROCESS DEVELOPMENT FOR LARGE SCALE MANUFACTURING PROCESSES

机译:使用AMBR 250以实现大规模制造过程的快速克隆选择和过程开发

获取原文

摘要

Currently, widely used bench scale bioreactor systems require much user manipulation, a large amount of raw materials, and have a long turnaround time for reactor cleaning and rebuilding. New technologies such as robotic disposable bioreactor systems provide a solution that is miniaturized, high throughput, and substantially automated. The Ambr? 250 offers such a solution, with 24x250mL bioreactors controlled independently. Although this new technology is rapidly being adopted by several groups as a way to increase efficiency and speed within upstream development, it remains to be proven that these systems are complete models for process characterization. We have shown that Ambr 250 is a good scale down model for multiple cell line systems. The aim of this work is to further characterize the engineering environment of the Ambr? 250 with a view of defining its role in industrial cell culture process development and scale-up. CFD modeling of the Ambr 250 mammalian vessel with validation via Particle Image Velocimetry (PIV) was conducted to simulate the hydrodynamic environment in the vessel. These findings were evaluated against current benchtop models and manufacturing scales. Cultures were run utilizing different engineering parameters (vvm, P/V, kLa) to assess the scalability of the current system. Cell growth, production, and product quality were compared across to recommend operating conditions for the Ambr? 250 that best match manufacturing scale reactors. Multiple CHO host cell lines were examined in order to find optimal operating conditions for the Ambr? 250 system.
机译:目前,广泛使用的台式生物反应器系统需要大量的用户操纵,大量的原料,并且具有长期的转截止时间,用于反应堆清洁和重建。机器人一次性生物反应器系统等新技术提供了一种小型化,高通量和基本上自动化的解决方案。 AMBR? 250提供这样的解决方案,具有24x250ml生物反应器,独立控制。虽然这项新技术正在通过几个群体迅速采用,但是一种提高上游开发内的效率和速度的方法,仍有待证明这些系统是过程表征的完整模型。我们已经表明,AMBR 250是多个细胞系系统的良好规模的模型模型。这项工作的目的是进一步表征AMBR的工程环境? 250目的是在工业细胞培养过程开发和扩大方面定义其作用。 AMBR 250哺乳动物血管的CFD建模,通过粒子图像测速仪(PIV)进行验证以模拟容器中的流体动力环境。这些发现针对当前的台式模型和制造规模进行了评估。利用不同的工程参数(VVM,P / V,KLA)进行培养,以评估当前系统的可扩展性。比较细胞生长,生产和产品质量,以为AMBR推荐操作条件? 250最佳匹配制造规模反应堆。检查多种CHO主机线,以便为AMBR找到最佳操作条件? 250系统。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号